News
A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...
Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...
Plants face simultaneous abiotic (drought, salinity, heat) and biotic (pathogens, pests) stresses in natural and agricultural ...
13h
Zacks Investment Research on MSNCRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should KnowCRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
The study documents a dramatic rise in research output since 2010, with publication volumes peaking at 344 in 2024, up from ...
There's a strong case that healthcare is the most important sector in the stock market. Investors stand to benefit as ...
The average Wall Street analyst following Editas Medicine ( EDIT 7.08%) thinks the gene therapy stock can reach $3.25 per ...
3d
Fintel on MSNClear Street Downgrades CRISPR Therapeutics (CRSP)Fintel reports that on June 27, 2025, Clear Street downgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from Buy ...
I n a world first, scientists have created mice with two fathers, capable of having offspring of their own. It’s a huge step ...
Scientists have discovered how to turn molecules made by everyday toxic mold into highly effective cancer-fighting drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results